Bridgebio Pharma Inc (BBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -538,303 | -353,366 | -169,608 | -543,347 | -275,958 |
| Depreciation Amortization | 3,999 | 2,601 | 1,284 | 6,075 | 4,708 |
| Accounts receivable | N/A | -72,146 | -110,543 | N/A | N/A |
| Accounts payable and accrued liabilities | 9,084 | 16,516 | 17,571 | 1,512 | 5,257 |
| Other Working Capital | -100,675 | -96,744 | -116,166 | 32,042 | 19,097 |
| Other Operating Activity | 236,405 | 223,223 | 178,227 | -17,008 | -78,504 |
| Operating Cash Flow | $-389,490 | $-279,916 | $-199,235 | $-520,726 | $-325,400 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,064 | -594 | N/A | -933 | -886 |
| Purchase Of Investment | -10,876 | -7,908 | N/A | -114,082 | -114,082 |
| Sale Of Investment | 8,000 | N/A | N/A | 158,229 | 158,229 |
| Purchase Sale Intangibles | -8,495 | -6,095 | -1,595 | -7,975 | -4,785 |
| Other Investing Activity | -6,193 | -6,095 | -1,595 | 17,567 | 20,757 |
| Investing Cash Flow | $-10,133 | $-14,597 | $-1,595 | $60,781 | $64,018 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 575,000 | 575,000 | 575,000 | 422,487 | 450,000 |
| Debt Repayment | -459,000 | -459,000 | -459,000 | -473,417 | -473,417 |
| Common Stock Issued | 20,937 | 12,917 | 5,758 | 322,899 | 320,051 |
| Common Stock Repurchased | -55,072 | -52,047 | -50,052 | -7,526 | -6,122 |
| Other Financing Activity | 279,610 | 285,499 | -11,378 | 484,014 | -15,986 |
| Financing Cash Flow | $361,475 | $362,369 | $60,328 | $748,457 | $274,526 |
| Beginning Cash Position | 683,244 | 683,244 | 683,244 | 394,732 | 394,732 |
| End Cash Position | 645,096 | 751,100 | 542,742 | 683,244 | 407,876 |
| Net Cash Flow | $-38,148 | $67,856 | $-140,502 | $288,512 | $13,144 |
| Free Cash Flow | |||||
| Operating Cash Flow | -389,490 | -279,916 | -199,235 | -520,726 | -325,400 |
| Capital Expenditure | -1,064 | -594 | N/A | -933 | -886 |
| Free Cash Flow | -390,554 | -280,510 | -199,235 | -521,659 | -326,286 |